Hypertension

Published on 06/06/2015 by admin

Filed under Pediatrics

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1340 times

47 Hypertension

Hypertension, the abnormal elevation of systolic blood pressure (SBP) or diastolic blood pressures (DBP), is relatively uncommon in children. It is usually divided into primary, or essential, hypertension and secondary hypertension (that which has a clear cause). In either case, elevated BP may result in significant damage to multiple organ systems, proportional to both the magnitude and duration of its elevation.

Etiology And Pathogenesis

Definitions

Normative BP ranges in adults have been based on long-term, end-organ risk as determined by large-cohort epidemiologic data. In children and adolescents, normal BP ranges have been defined based on data from relatively large cohort studies in presumed-healthy subjects and are stratified by gender, age, and height. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC7) and the Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents (Fourth Report) (NHBPEP) define hypertension in children and adolescents as an average SBP or DBP at the 95th percentile or above for gender, age, and height on three or more occasions. BPs (SBP or DBP) between the 90th and 95th percentiles have historically been referred to as “high normal” but in these most recent guidelines have been redefined as prehypertensive. This change reflects the addition of prehypertension to the adult diagnostic criteria as defined by JNC7; there is increased risk of developing hypertension in those with prehypertension. Stage 1 hypertension is defined as a BP above the 95th and up to 5 mm Hg over the 99th percentile for gender, age, and height. Stage 2 hypertension is more than 5 mm Hg higher than the 99th percentile. More timely antihypertensive therapy is recommended for stage 2 hypertension.

White coat hypertension is defined as having a BP consistently above the 95th percentile for age in a physician’s office or clinic but being normotensive outside of the clinical setting. This diagnosis usually requires ambulatory BP monitoring for confirmation.

There are many causes of hypertension (Figure 47-1). Whereas BP for which a clear cause can be determined is described as secondary hypertension, hypertension without a clear correctable cause is referred to as primary or essential hypertension. This is necessarily a diagnosis of exclusion.

Physiology

BP is determined by both cardiac output (CO) and systemic vascular resistance (SVR). Factors increasing output or resistance can result in hypertension. The relationship between BP and CO is summarized by the following equations.

image

image

Multiple causes of secondary hypertension are shown in Figure 47-1. Each condition may increase BP via increases in heart rate, SV, or SVR. Considering these three fundamental factors in BP elevation aids in the appropriate therapeutic approach to a given patient.

Evaluation

Cuff Size and Location

Cuff size also dramatically affects the BP measurement. Cuffs that are too small overestimate BP, and excessively large cuffs may underestimate BP. However, the range of the underestimation with a large cuff is generally smaller in magnitude than errors from very small cuffs. The correct cuff size can be obtained by insuring that the inflatable bladder has (1) a width that is approximately 40% of the arm circumference (or ≈25% greater than the diameter of the arm) at the point midway between the olecranon and acromion and (2) enough length to cover 80% to 100% of the arm circumference. The length-to-width ratio should be approximately 2 : 1, which is not true of all commercial cuffs.

For appropriate auscultation, the stethoscope should be placed over the site of the brachial pulse proximal and medial to the cubital fossa below the distal border of the cuff. Measurement using the bell (instead of the diaphragm) produces superior discrimination of the Korotkoff sounds. The SBP corresponds to the pressure at which the first Korotkoff sound is audible, and the DBP corresponds to the pressure at which the fifth Korotkoff sound is audible or with obliteration of the last sound. If sounds are still heard at 0 mm Hg, a repeat BP should be attempted with less pressure on the stethoscope head.

The measured BP should be compared against BP tables that have been published by the American Academy of Pediatrics, which are normalized for gender, age, and height percentile.

Diagnostic Approach

Before making a diagnosis of hypertension, it is important to rule out immediate causes of transient BP elevations such as acute pain, anxiety, or medication exposure. After such causes have been ruled out, the diagnostic approach in a patient with hypertension can be organized as follows: (1) define the degree of hypertension, (2) investigate end-organ damage, and (3) evaluate for possible causes of secondary hypertension (see Figure 47-1).

Primary or essential hypertension is generally characterized by stage 1 hypertension, is often associated with family history of hypertension or coronary vascular disease, and frequently coincides with obesity. Because of the well-documented comorbidity of hypertension, obesity, hypercholesterolemia, and insulin insensitivity, screening for these other cardiovascular disease risk factors is sensible. Currently, a fasting lipid profile and fasting glucose are recommended as initial screening tests. There are not sufficient data at present to recommend testing plasma uric acid, homocysteine, or lipoprotein A in children with high BP.

Secondary, as opposed to primary, hypertension is more common in children than adults, in whom primary or essential hypertension is overwhelmingly the most common cause. Generally, secondary hypertension is more likely in patients who (1) have stage 2 hypertension, (2) are young (i.e., not adolescents), and (3) have signs or symptoms of systemic disease or have a personal or family medical history of those conditions. As summarized in Figure 47-1, there are numerous causes of secondary hypertension. The history and physical examination should screen for signs and symptoms of causes of secondary hypertension. The physical should include a measurement of height and weight to calculate body mass index. Upper and lower extremity BPs must always be measured. Additional studies should be tailored to the individual patient based on their presentation. Studies should be divided between those seeking the cause of secondary hypertension and those that identify the stigmata of hypertensive end-organ damage.

In patients with stage 2 hypertension, it is important to immediately screen for signs and symptoms of end-organ damage. Hypertensive urgency refers to high BP without evidence of end-organ damage Hypertensive emergency is defined as having acute, end-organ dysfunction, such as neurologic symptoms, vision changes, cardiac chest pain, or acute renal failure, in the setting of marked hypertension. Hypertensive urgency and emergency require immediate intervention to control BP.

Management

Long-term outcomes data for hypertension control in children and adolescents are not available, and the degree to which reducing BP will affect morbidity and mortality is unknown. The goal of antihypertensive therapy is to reduce BP to reduce the long-term risk of accumulating end-organ damage without incurring excessive side effects. Current recommendations are to reduce the BP below the 95th percentile if no other risk factors are present or below the 90th percentile if other risk factors, such as diabetes mellitus, dyslipidemia, or kidney disease, are present.

The first-line therapy for stage 1 hypertension and prehypertension is therapeutic lifestyle change. Data supporting the efficacy of these modifications are limited; however, based on data from studies in adult groups, weight reduction in obese patients, increased intake of vegetables and fruits, increased physical activity, and reduction in dietary sodium intake are all recommended. The recommendations for moderate alcohol consumption are, hopefully, not applicable in children and adolescents. Smoking cessation, if applicable, is also recommended based on the known myriad cardiovascular benefits in adults.

Indications for pharmacologic intervention include insufficient response to therapeutic lifestyle modifications and identification of secondary hypertension, which cannot be corrected otherwise. There is no consensus regarding the choice of antihypertensive medications, although dihydropyridine calcium channel blockers such as amlodipine are frequently first-line medications in many groups. Treatment choice is empiric and generally guided by the cause of the hypertension, especially in secondary hypertension. Medication classes include calcium channel blockers, β-blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and diuretics (Figure 47-3). Other agents such as clonidine, prazosin, and minoxidil are primarily used by subspecialists (see Figure 47-3). Data regarding pediatric dosing of most antihypertensive medications are expanding.

The management of hypertensive urgency and emergency must be considered separately. Therapy should be initiated immediately with simultaneous diagnostic workup. The goal of pharmacologic intervention in hypertensive urgency is to reduce the BP to an appropriate level within 24 to 48 hours. In the setting of hypertensive emergency, the goal is to reduce the mean arterial pressure by no more than 25% (within minutes to 2 hours). The BP should then be lowered slowly to a normal level over the next 48 hours. A trial of oral agents (e.g., nifedipine or hydralazine) should be attempted in the setting of hypertensive urgency; however, in hypertensive emergency, intravenous (IV) medications should be used. IV antihypertensive agents, such as nicardipine, esmolol, and nitroprusside, can be given via bolus or continuous infusion, are titratable, and have shorter times to onset. Any patient with a hypertensive emergency or those with hypertensive urgency requiring a continuous infusion should be admitted to a pediatric intensive care unit or other facility with staffing and equipment necessary for BP monitoring. Arterial access for continuous BP monitoring may also be necessary.

In patients with hypertensive nephropathy and severe volume overload, renal replacement therapy with dialysis or ultrafiltration may be an effective intervention. Temporary hemodialysis typically is reserved for patients with hypertensive emergencies that include overt renal failure with resultant volume overload and severe electrolyte imbalances.